- Home
- BL vs PLSE Comparison
BL vs PLSE Comparison
Compare BL & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BL | PLSE |
|---|---|---|
| Founded | 2001 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 2016 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BL | PLSE |
|---|---|---|
| Price | $28.44 | $25.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 1 |
| Target Price | ★ $56.62 | $22.00 |
| AVG Volume (30 Days) | ★ 1.5M | 366.1K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $177,031,000.00 | N/A |
| Revenue This Year | $12.62 | $840.00 |
| Revenue Next Year | $10.90 | $287.54 |
| P/E Ratio | $220.85 | ★ N/A |
| Revenue Growth | ★ 43.78 | N/A |
| 52 Week Low | $24.70 | $12.56 |
| 52 Week High | $59.57 | $28.53 |
Technical Indicators
Market Signals| Indicator | BL | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 45.60 | 53.84 |
| Support Level | $25.49 | $17.58 |
| Resistance Level | $30.93 | $26.30 |
| Average True Range (ATR) | 1.96 | 1.62 |
| MACD | 0.21 | -0.05 |
| Stochastic Oscillator | 41.75 | 28.60 |
Price Performance
Historical ComparisonAbout BL BlackLine Inc.
BlackLine Inc is engaged in providing financial accounting close solutions delivered as Software as a Service (SaaS). The Company's solutions enable its customers to address various aspects of their critical processes, including financial close & consolidation, intercompany accounting, and invoice-to-cash. The majority of the revenue of the company is earned in the United States.
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.